$134.80
▼ -0.0% Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
TFX: Raising target price to $142.00
Teleflex Signs Central Venous Access Deal With Premier
Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.
Overview
52-week range
$100
$140
88% of range
Avg surprise (last 3)
+9.0%
Avg reaction (last 2)
-0.7%
50% positive
Latest IV / EM
45%
EM ±10.4% · $135 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.39 | $1.21 | +14.9% | -52.2% | +6.9% | earnings |
| Sun Sep 28, 2025 | Sep 2025 | $-9.24 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $3.73 | $3.36 | +11.0% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $2.91 | $2.88 | +1.0% | — | -8.2% | earnings |
| Sun Sep 29, 2024 | Sep 2024 | $2.36 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.69 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.32 | — | — | — | — | financials |
| Sun Oct 1, 2023 | Oct 2023 | $2.90 | — | — | — | — | financials |
| Sun Jul 2, 2023 | Jul 2023 | $2.35 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | OTHER | $1.28 | $3.73 | -65.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $548M | — | $913M | $781M | $414M | — | $764M | $750M |
| Cost of revenue | $241M | — | $461M | $350M | $159M | — | $334M | $333M |
| Gross profit | $307M | — | $452M | $431M | $255M | — | $430M | $416M |
| Operating income | $20M | — | $-409M | $155M | $76M | — | $149M | $117M |
| Net income | $-8M | — | $-409M | $123M | $95M | — | $111M | $80M |
| EPS (diluted) | $-0.18 | — | $-9.24 | $2.77 | $2.07 | — | $2.36 | $1.69 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $309M | $379M | $354M | $254M | $284M | $290M | $243M | $239M |
| Inventory | $381M | $404M | $802M | $694M | $644M | $600M | $640M | $637M |
| Total current assets | $1.86B | $1.94B | $1.99B | $1.72B | $1.54B | $1.47B | $1.50B | $1.44B |
| Total assets | $6.78B | $6.95B | $7.87B | $7.38B | $7.16B | $7.10B | $7.49B | $7.44B |
| Long-term debt | $2.51B | $2.54B | $2.57B | $1.80B | $1.81B | $1.56B | $1.66B | $1.62B |
| Total liabilities | $3.70B | $3.82B | $4.05B | $3.13B | $3.07B | $2.82B | $3.00B | $2.88B |
| Total equity | $3.08B | $3.12B | $3.82B | $4.24B | $4.10B | $4.28B | $4.48B | $4.56B |